FILTER

Refine your search with the following facets to narrow down your results.

8 Current news of genethon

Généthon receives the 2012 Galien Prize for its Innovative Treatments in Gene Therapy

09-Oct-2012 - The 43rd Prix Galien recognized Généthon for its innovative treatments of rare diseases using gene therapy and awarded it the prize in the category of "Medicines destined for rare diseases - cell therapy and gene therapy." Created in 1990 by a patient association, the AFM-Téléthon, and 90% ...

rare diseases

Alain Schwenck becomes Director of Genethon Bioprod

09-Jul-2012 - Alain Schwenck, 51, has joined Genethon as Director of Genethon Bioprod, the new site for the production of clinical grade-gene therapy medicines for the treatment of rare diseases, created by AFM-Telethon. Mr. Schwenck is a seasoned expert in manufacturing of pharmaceutical products. He began ...

appointments

Fulvio Mavili is appointed as Généthon's new Scientific Director

19-Jan-2012 - Fulvio Mavilio, PhD (aged 58), an international acknowledged expert and pioneer in gene therapy for rare diseases for more than twenty years, was appointed as the new Scientific Director of Généthon (the not-for-profit biotherapy lab funded by the French Muscular Dystrophy Association (AFM) with ...

appointments

Encouraging results in a Phase I clinical trial in limb-girdle muscular dystrophy type 2C

16-Jan-2012 - The results of a Phase I clinical trial of gene therapy for limb-girdle muscular dystrophy type 2C (a rare neuromuscular disease) have just been published in the journal Brain. The trial started in December 2006 and has been sponsored by Généthon (the not-for-profit research lab created by the ...

clinical trials gene therapy

bluebird bio and Généthon Announce Manufacturing Research Collaboration

20-Dec-2010 - bluebird bio (formerly Genetix Pharmaceuticals Inc.) and Généthon announced a research collaboration focused on process development and scale up efforts for the manufacturing of lentiviral vectors. This agreement is designed to enable substantial advances in existing manufacturing process for the ...

Généthon initiates a new clinical trial for a severe immune deficiency (Wiskott-Aldrich syndrome)

01-Mar-2010 - Généthon has just obtained approval from the French and British health authorities for a Phase I/II clinical trial of gene therapy for a rare immunodeficiency, Wiskott-Aldrich syndrome (WAS). The Généthon-sponsored trial will be performed both in France (led by Professors Alain Fischer and Marina ...

clinical trials gene therapy genes +7

Généthon appoints biopharma industry expert Frédéric Revah as Chief Executive

24-Feb-2010 - Généthon announced the appointment of Frédéric Revah PhD as Chief Executive. Frédéric Revah brings over 20 years' experience in the pharmaceutical and biotech industries and academic research to the job. Immediately prior to joining Généthon in January 2010, Frédéric Revah had been Chief ...

central nervous system gene therapy neurochemistry +3

bioMérieux will be awarded up to EUR54.5 million by France's Agence de l'Innovation Industrielle for molecular biology research

28-Nov-2006 - bioMérieux announced that it will be awarded up to EUR54.5 million over the next ten years by France's Agence de l'Innovation Industrielle to help fund the "Advanced Diagnostics and New therapeutic Approaches" (ADNA) program, led by Mérieux Alliance. Of this amount, EUR25.6 million will be in the ...

biomarkers diagnostic tests diagnostics +4